B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Vatalanib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Vatalanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

semaxanib
8 shared targets
motesanib
15 shared targets
pexidartinib
6 shared targets
brivanib
11 shared targets
tivozanib
10 shared targets
raf
15 shared targets
lucitanib
6 shared targets
ilorasertib
7 shared targets
cabozantinib
9 shared targets
bemcentinib
6 shared targets
Loading evidence profile...

This evidence profile for Vatalanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.